Back to News
Market Impact: 0.2
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc.
Source: prnewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP announced an investigation into potential claims on behalf of investors in SELLAS Life Sciences Group (NASDAQ: SLS). The notice provides no allegations, financial damages, regulatory action, or operating updates, but may create a modest litigation-related overhang for the biotech company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
SLS-0.75
More News
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Jefferies raises West Pharmaceutical stock price target on HVP growth
- People Inc earnings up next after MGM deal collapse
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Wells Fargo raises Regeneron stock price target to $925 on execution